People · Operator
Named in public records as an officer, director or promoter · active 2017–2020 · Healthtech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Net Health Parent Holdings, L.P. | — | Healthtech | Series D+ | $160.6M | $3.9B | 2017 |
| Lengo Therapeutics, Inc. | — | Pharmaceuticals | Series B | $17.7M | $601.9M | 2020 |
Steve Bailey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steve Bailey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Johnson | 1 | 35 |
| Anna Chen | 1 | 3 |
| Donna Morea | 1 | 2 |
| Helen Jenkins | 1 | 2 |
| Anthony Sanzo | 1 | 2 |
| Daniel Estes, Ph.D. | 1 | 2 |
| Chris Hayes | 1 | 2 |
| Ben Levin | 1 | 2 |
| N/A CEOF II GP, L.L.C. | 1 | 1 |
| N/A CEOF II GP, L.P. | 1 | 1 |
| William Winkenwerder | 1 | 1 |
| Patrick Colletti | 1 | 1 |
| Michael Gozycki | 1 | 1 |
| Roger Ulrich, Ph.D. | 1 | 1 |
| Tracy Saxton, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.